Skip to main content
Ingredients/Peptide/SS-31 (Elamipretide)

SS-31 (Elamipretide).

Strength pending.The research strength is not set yet.

Targets mitochondria directly. In clinical trials for heart failure.

10 to 40mgDaily amount181Studies read

Reviewed March 2026

SEPeptide
SS-31 (Elamipretide)IngredientMD
Category
Peptide

Also filed under
Mitochondrial functionCardioprotectionExercise capacity

What SS-31 (Elamipretide) is, and what it does.

Does it work
This is an investigational injectable peptide used under medical supervision. It suits research settings rather than a daily supplement routine, since it is not orally available.
How much to take
The record shows 10mg to 40mg a day, with 80mg as a research condition. It is a peptide with negligible oral availability, so those figures come from injected use.
Time to feel it
Changes in exercise tolerance reported in trial settings took weeks of daily dosing. Nobody has measured a timeline for any oral form.
The first dose
Nothing has been characterised for day one outside a clinical setting. It reaches the inner mitochondrial membrane quickly, but that is chemistry rather than sensation.
With regular use
Most effects take 2-8 weeks. Be patient.
How well tolerated
Generally well tolerated. Check with your doctor if on medications.
How it feels
Improved energy and exercise tolerance in clinical trials.
The overlooked benefit
Its uptake into the inner mitochondrial membrane does not depend on membrane potential, so it still reaches mitochondria that have lost their charge gradient.

10 to 40mg a day is where SS-31 (Elamipretide) works.

How much to take a dayLimited data
10 to 40mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
80mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 100mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑040mg80mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Szeto, AAPS J, 2006; Stealth BioTherapeutics clinical trials for mitochondrial disease

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

SS-31 (Elamipretide) has emerging evidence. Based on 181+ studies.

  • Binding to cardiolipin in the inner mitochondrial membraneIn vitro study
  • Cristae architecture and reduced electron leakAnimal study
  • Lowering cardiolipin-bound cytochrome c peroxidase activityIn vitro study
  • Exercise tolerance measuresRandomised trial
  • Skeletal muscle mitochondrial functionRandomised trial
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI181 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI181 studies readLabs test. IngredientMD verifies.

Questions people ask about SS-31 (Elamipretide).

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Who benefits most from this?
Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
Pairs well with15 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

SS-31 (Elamipretide) + CoQ10 (Ubiquinol)both act at the inner mitochondrial membrane

SS-31 binds cardiolipin and helps hold cristae structure and respiratory supercomplexes together, which is the environment ubiquinol shuttles electrons through. Structural support and electron carrier supply address different halves of the same membrane.

SS-31 (Elamipretide) + Nicotinamide Riboside (NR/Niagen)complementary mitochondrial mechanisms

NAD precursors raise cofactor availability for the electron transport chain and sirtuin signalling, while SS-31 acts on cristae architecture rather than cofactor supply. The two touch separate limits on mitochondrial output.

SS-31 (Elamipretide) + PQQcomplementary mitochondrial mechanisms

PQQ signals through PGC-1alpha toward making new mitochondria while SS-31 works on the membrane structure of existing ones. Building capacity and maintaining capacity are different levers.

SS-31 (Elamipretide) + Urolithin Acomplementary mitochondrial quality control

Urolithin A promotes mitophagy, the clearance of damaged mitochondria, while SS-31 supports the cardiolipin-dependent structure of those that remain. Clearance and maintenance are distinct arms of mitochondrial quality control.

SS-31 (Elamipretide) + Vitamin B2 riboflavinEstablished cofactor chemistry: riboflavin is the precursor of FMN and FAD, the prosthetic groups of complex I and complex II.

Complex I carries FMN and complex II carries FAD, and both are built from riboflavin. Stabilising the membrane those complexes sit in does nothing if the flavin cofactors are short. This is textbook cofactor dependency rather than a tested combination.

SS-31 (Elamipretide) + MagnesiumEstablished enzymology: magnesium is the obligate counter-ion for ATP and for ATP synthase activity.

Nearly every ATP-handling step runs on the Mg-ATP complex, not on free ATP. Any intervention aimed at oxidative phosphorylation depends on adequate magnesium for the output to be usable. The relationship is cofactor supply, not a demonstrated synergy.

SS-31 (Elamipretide) + Acetyl L carnitineEstablished transport biochemistry: carnitine shuttles long-chain fatty acyl groups across the inner mitochondrial membrane.

Fatty acids cannot cross the inner membrane without the carnitine shuttle, and the carnitine-acylcarnitine translocase sits in that membrane alongside cardiolipin. A compound that binds cardiolipin and preserves membrane organisation and a compound that supplies the shuttle substrate address adjacent steps in fat oxidation. Human data on the pair are absent.

SS-31 (Elamipretide) + PhosphatidylcholineEstablished lipid biosynthesis: cardiolipin, the lipid SS-31 binds, is assembled from phosphatidylglycerol derived from the same glycerophospholipid pathway that produces phosphatidylcholine.

Cardiolipin is synthesised inside the mitochondrion from CDP-diacylglycerol and phosphatidylglycerol, and it is remodelled using acyl chains drawn from phosphatidylcholine by tafazzin. SS-31 binds the cardiolipin that already exists; phospholipid substrate supply is what determines how much there is to bind. The link is biosynthetic, not a tested pairing.

SS-31 (Elamipretide) + Creatine monohydrateEstablished energy buffering: the creatine phosphate shuttle moves high-energy phosphate from the mitochondrion to the cytosol.

Mitochondrial creatine kinase is associated with the inner membrane and depends on local ATP output. Raising the creatine pool supports phosphate transfer downstream of oxidative phosphorylation, a different step from membrane stabilisation. Combination evidence does not exist.

SS-31 (Elamipretide) + TaurineEstablished mitochondrial biochemistry: taurine modification of mitochondrial tRNA is required for correct translation of mitochondrially encoded respiratory subunits.

Taurine-modified mitochondrial tRNA is needed to translate the subunits of the respiratory complexes, and taurine also influences membrane calcium handling. That places it upstream of the complexes whose organisation SS-31 preserves. This row is biochemistry, not clinical evidence.

SS-31 (Elamipretide) + AstaxanthinEstablished membrane chemistry: astaxanthin spans the lipid bilayer and quenches radicals within it.

Peroxidation of cardiolipin acyl chains is one route by which inner-membrane organisation is lost. A membrane-spanning carotenoid intercepts radicals in that same lipid phase, while SS-31 binds cardiolipin directly. The two target the same lipid from different angles; no human combination data exist.

SS-31 (Elamipretide) + GlutathioneEstablished mitochondrial redox: the mitochondrial glutathione pool detoxifies peroxides generated by electron leak.

Mitochondria import glutathione rather than making it in place, and that pool is what glutathione peroxidase uses to clear hydrogen peroxide from electron leak. SS-31 is described as lowering the peroxidase-like activity of cardiolipin-bound cytochrome c, which lowers one source of that stress. Both act on mitochondrial peroxide handling, at separate points.

SS-31 (Elamipretide) + MelatoninEstablished distribution and chemistry: melatonin concentrates in mitochondria and scavenges radicals there.

Melatonin accumulates in the mitochondrial matrix and membranes at concentrations above plasma and reacts directly with oxidants. That overlaps in location with a cardiolipin-binding peptide. The overlap is anatomical and chemical; no trial of the pair is available.

SS-31 (Elamipretide) + Alpha lipoic acidEstablished enzymology: lipoic acid is the covalently bound cofactor of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase.

Both of those dehydrogenase complexes sit in the mitochondrial matrix and cannot run without their lipoamide arm. Supplemental lipoic acid also enters the cellular thiol pool. This is a cofactor and redox relationship rather than a demonstrated combination effect.

SS-31 (Elamipretide) + SpermidineEstablished autophagy biology: spermidine induces autophagy, including turnover of damaged mitochondria.

Mitochondrial quality control has two arms, keeping existing organelles functional and clearing the ones that are not. A cardiolipin-binding peptide addresses the first; spermidine-induced autophagy addresses the second. Externalised cardiolipin is also a recognition signal in mitophagy, so the interaction could run either way and has not been measured in people.

Who should be cautious

Nothing specific on file for SS-31 (Elamipretide). Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What SS-31 (Elamipretide) actually does.

Established

It is a four-amino-acid synthetic peptide built to slip through cell membranes and collect in the inner wall of the mitochondrion without needing an electrical gradient to pull it there.

Established

It sticks to cardiolipin, a fat found only in the inner mitochondrial membrane, rather than to a protein receptor.

Established

Unnatural building blocks make it survive enzymes that chew up normal peptides, but digestion still applies, so it has been given by injection or as eye drops in research rather than swallowed.

Strong

Cardiolipin holds the energy-producing machinery in place. Keeping it organised is the proposed reason membrane structure and electron flow hold up better.

Getting SS-31 (Elamipretide) from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Varied whole foods

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

Elamipretide acetateThe tetrapeptide isolated as an acetate salt; the three basic side chains mean it is handled as a polycationic salt with counter-ions.Fits The salt form used in investigational parenteral preparations, where an acetate counter-ion is well characterised in injectable products.Trade-off Counter-ion mass changes the peptide content per milligram of powder, so a stated weight needs the salt named alongside it.
Lyophilised powderFreeze-dried peptide, sometimes with a bulking agent, dissolved in aqueous vehicle before use.Fits Extends shelf life of a peptide that hydrolyses and aggregates in solution.Trade-off Requires reconstitution and cold handling, and once in solution the stability window is short.
What the strongest studies found

The essence, in one line each.

  1. Pooling human trials of mitochondria-targeted antioxidants as a class, the review examined effects on blood sugar control, vascular measures and markers of oxidative stress.Meta-analysis. Mason et al., 2022 (Diabetes, obesity & metabolism). PMID 35165982
  2. Elamipretide added during in vitro production of porcine embryos changed mitochondrial and developmental measures in the culture system; the authors describe the protective potential as in vitro.In vitro study. Nguyen et al., 2025 (Animals). PMID 40941292
  3. A review of mitochondria-targeted compounds that names elamipretide among the cardiolipin-binding, mitochondrially targeted agents under investigation; it is a summary of the field rather than new data.Narrative review. Lores-Arnaiz et al., 2026 (Biology). PMID 41677699

These are the studies our verdict leans on, chosen from the 205 we read for SS-31 (Elamipretide). The full linked list is below.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.